Endothelin levels in experimental diabetes combined with cardiac hypertrophy

被引:0
|
作者
Skoumal, R
Seres, L
Soós, P
Balogh, E
Kovàts, T
Rysa, J
Ruskoaho, H
Tóth, M
Horkay, F
机构
[1] Semmelweis Univ, Dept Internal Med 1, H-1083 Budapest, Hungary
[2] Gyorgy Gottsegen Natl Inst Cardiol, Budapest, Hungary
[3] Oulu Univ, Dept Pharmacol & Toxicol, SF-90220 Oulu, Finland
[4] Hungarian Acad Sci, Mol Genet Res Grp, H-1051 Budapest, Hungary
关键词
endothelin; cardiac hypertrophy; diabetes;
D O I
10.1097/01.fjc.0000166240.41830.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P < 0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.
引用
收藏
页码:S195 / S197
页数:3
相关论文
共 50 条
  • [1] Cardiac expression of inatruretic substances in experimental diabetes mellitus combined with all induced cardiac hypertrophy
    Toth, M
    Ruzicska, E
    Foldes, G
    Jenei, V
    Skoumal, R
    Ruskoaho, H
    Somogyi, A
    deChatel, R
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A178 - A178
  • [2] Cardiac expression of natriuretic substances in experimental diabetes mellitus combined with angiotensin II induced cardiac hypertrophy
    Ruzicska, E
    Sarman, B
    Foldes, G
    deChàtel, R
    Heikki, R
    Toth, M
    Somogyi, A
    DIABETOLOGIA, 2001, 44 : A306 - A306
  • [3] LEVELS OF PHOSPHATE COMPOUNDS IN EXPERIMENTAL CARDIAC HYPERTROPHY
    MINTON, PR
    ZOLL, PM
    NORMAN, LR
    CIRCULATION RESEARCH, 1960, 8 (05) : 924 - 929
  • [4] Cardiac expression of natriuretic substances in experimental diabetes mellitus combined with either angiotensin II induced cardiac hypertrophy or insulin treatment
    Ruzicska, É
    Sármán, B
    Pusztai, P
    Ruskoaho, H
    Toth, M
    Somogyi, A
    DIABETOLOGIA, 2003, 46 : A359 - A359
  • [5] Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy
    Hong, Y
    Hui, SSC
    Chan, BTY
    Hou, JY
    LIFE SCIENCES, 2003, 72 (22) : 2499 - 2507
  • [6] Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro
    Bupha-Intr, Tepmanas
    Haizlip, Kaylan M.
    Janssen, Paul M. L.
    PLOS ONE, 2012, 7 (08):
  • [7] EXPERIMENTAL CARDIAC HYPERTROPHY
    FANBURG, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (13): : 723 - +
  • [8] Sunitinib-induced cardiac hypertrophy and the endothelin axis
    Sourdon, Joevin
    Address, Corresponding
    Facchin, Caterina
    Certain, Anais
    Viel, Thomas
    Robin, Blaise
    Lager, Franck
    Marchiol, Carmen
    Balvay, Daniel
    Yoganathan, Thulaciga
    Favier, Judith
    Tharaux, Pierre-Louis
    Dhaun, Neeraj
    Renault, Gilles
    Tavitian, Bertrand
    THERANOSTICS, 2021, 11 (08): : 3830 - 3838
  • [9] Cardiac hypertrophy in experimental nephritis
    Duguid, JB
    Aberd, MD
    LANCET, 1935, 2 : 421 - 422
  • [10] RENAL HYPERTROPHY IN EXPERIMENTAL DIABETES
    SEYERHANSEN, K
    ORSKOV, H
    ACTA ENDOCRINOLOGICA, 1977, 85 : 56 - 57